Literature DB >> 15961562

Expression, regulation, and function of paired-box gene 8 in the human placenta and placental cancer cell lines.

Elisabetta Ferretti1, Franco Arturi, Tiziana Mattei, Angela Scipioni, Gianluca Tell, Emanuele Tosi, Ivan Presta, Roberta Morisi, Ludovic Lacroix, Alberto Gulino, Diego Russo, Giuseppe Damante, Sebastiano Filetti.   

Abstract

Pax proteins are transcriptional regulators that control a variety of developmental decisions in vertebrates. During development, the paired-box gene 8 (PAX8) is expressed in the thyroid, kidney, and several areas of the central nervous system. It is also expressed in the adult thyroid gland, in which it mediates TSH-induced modulation of the expression of important genes, such as those encoding thyroglobulin, thyroperoxidase, and the sodium/iodide symporter (NIS). Thus far, placental expression of PAX8 has been described only in mice. In the present study, we show that PAX8 is also expressed in the human placenta at term. In an in vitro model of placental cancer, the JAR choriocarcinoma cell line, human chorionic gonadotropin (hCG) increased levels of PAX8 mRNA and protein, and gel retardation assays indicated that the up-regulation of PAX8 protein expression is associated with an increase in its DNA-binding activity. The effects of hCG were mimicked by forskolin, indicating that they are cAMP dependent. Levels of mRNA for the Wilms' tumor 1 (WT1) and NIS genes were increased in JAR cells by hCG treatment, whereas overexpression of PAX8 increased only levels of WT1 mRNA. In cells transfected with PAX8-specific small interfering RNA, the stimulatory effects of hCG on WT1 mRNA levels were abolished, but hormonal enhancement of NIS mRNA levels was unchanged. These findings indicate that, in JAR cells, hCG activates a cAMP-dependent pathway that can up-regulate WT1 expression through PAX8.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961562     DOI: 10.1210/en.2005-0084

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification.

Authors:  Yuzhi Yin; Hongyan Yuan; Xiao Zeng; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

2.  PAX Genes in Cancer; Friends or Foes?

Authors:  Caiyun G Li; Michael R Eccles
Journal:  Front Genet       Date:  2012-01-31       Impact factor: 4.599

3.  Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.

Authors:  Rajani Kanteti; Essam El-Hashani; Immanuel Dhanasingh; Maria Tretiakova; Aliya N Husain; Sherven Sharma; Jay Sharma; Everett E Vokes; Ravi Salgia
Journal:  BMC Cancer       Date:  2014-03-14       Impact factor: 4.430

4.  Maternal Vitamin and Mineral Supplementation and Rate of Maternal Weight Gain Affects Placental Expression of Energy Metabolism and Transport-Related Genes.

Authors:  Wellison J S Diniz; Lawrence P Reynolds; Pawel P Borowicz; Alison K Ward; Kevin K Sedivec; Kacie L McCarthy; Cierrah J Kassetas; Friederike Baumgaertner; James D Kirsch; Sheri T Dorsam; Tammi L Neville; J Chris Forcherio; Ronald R Scott; Joel S Caton; Carl R Dahlen
Journal:  Genes (Basel)       Date:  2021-03-09       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.